Diosmetin alleviates hypoxia‑induced myocardial apoptosis by inducing autophagy through AMPK activation

Si,Qijun; Shi,Yujie; Huang,Dandan; Zhang,Na

doi:10.3892/mmr.2020.11241

Diosmetin alleviates hypoxia‑induced myocardial apoptosis by inducing autophagy through AMPK activation

Authors:
- Qijun Si
- Yujie Shi
- Dandan Huang
- Na Zhang
View Affiliations

Affiliations: Clinical Laboratory, Zhuji People's Hospital, Zhuji, Zhejiang 311800, P.R. China, Cardiovascular Disease Institute, PLA Army General Hospital, Beijing 100000, P.R. China, Preclinical School, North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China, Department of Internal Medicine, The Hospital of Wuhan University, Wuhan, Hubei 430000, P.R. China
Published online on: June 16, 2020 https://doi.org/10.3892/mmr.2020.11241
Pages: 1335-1341
Copyright: © Si et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diosmetin has shown great potential in the control of several diseases. The aim of the present study was to evaluate the role of diosmetin as a candidate agent for the treatment of myocardial infarction which was mainly caused by hypoxia. The model of hypoxia‑injured myocardial cells was established using the H9c2 cell line. Cell viability was determined using Cell Counting Kit‑8, cell apoptosis was determined by Annexin V‑FITC Apoptosis Detection Kit and cleaved caspase‑3 level was assessed by western blot analysis. Autophagy was monitored using a commercial kit, and a well‑established reporter system was used to confirm the role of diosmetin in autophagy. The activity of adenosine 5'‑monophosphate‑activated protein kinase (AMPK) signaling was detected by western blot analysis. Cell viability assay indicated that diosmetin alleviated hypoxia‑induced cell death of H9c2 cells in a dose‑dependent manner. Data of the apoptosis assay revealed that diosmetin reduced the proportion of apoptotic cells in the hypoxia‑injured H9c2 cells. It was also found that the occurrence of autophagy was promoted when hypoxia‑injured cells were treated with diosmetin alone, and results of the western blot analysis revealed that AMPK signaling was activated by diosmetin. Administration of diosmetin together with an inhibitor of autophagy (3‑methyladenine, 3‑MA) or AMPK (Compound C) was able to decrease the diosmetin‑induced autophagy as well as the cytoprotective effects in the hypoxia‑injured cells. Our study concluded that diosmetin exhibits a cytoprotective effect on hypoxia‑injured myocardial cells by inducing autophagy and alleviating apoptosis. AMPK was demonstrated to regulate the observed effects caused by diosmetin. This investigation confirmed diosmetin as a promising drug candidate for myocardial infarction treatment. The present findings regarding the inherent molecular mechanisms involved in the protective effects of diosmetin promote the clinical application of diosmetin.

View Figures

View References

1	Li R, Geng HH, Xiao J, Qin XT, Wang F, Xing JH, Xia YF, Mao Y, Liang JW and Ji XP: miR-7a/b attenuates post-myocardial infarction remodeling and protects H9c2 cardiomyoblast against hypoxia-induced apoptosis involving Sp1 and PARP-1. Sci Rep. 6:290822016. View Article : Google Scholar : PubMed/NCBI
2	Huang Y, Chen JB, Yang B, Shen H, Liang JJ and Luo Q: RhoA/ROCK pathway regulates hypoxia-induced myocardial cell apoptosis. Asian Pac J Trop Med. 7:884–888. 2014. View Article : Google Scholar : PubMed/NCBI
3	Cheng WP, Lo HM, Wang BW, Chua SK, Lu MJ and Shyu KG: Atorvastatin alleviates cardiomyocyte apoptosis by suppressing TRB3 induced by acute myocardial infarction and hypoxia. J Formos Med Assoc. 116:388–397. 2017. View Article : Google Scholar : PubMed/NCBI
4	Liu B, Che W, Xue J, Zheng C, Tang K, Zhang J, Wen J and Xu Y: SIRT4 prevents hypoxia-induced apoptosis in H9c2 cardiomyoblast cells. Cell Physiol Biochem. 32:655–662. 2013. View Article : Google Scholar : PubMed/NCBI
5	Luo S, Gu X, Ma F, Liu C, Shen Y, Ge R and Zhu Y: ZYZ451 protects cardiomyocytes from hypoxia-induced apoptosis via enhancing MnSOD and STAT3 interaction. Free Radic Biol Med. 92:1–14. 2016. View Article : Google Scholar : PubMed/NCBI
6	Ashok A, Kanwar JR, Krishnan UM and Kanwar RK: SurR9C84A protects and recovers human cardiomyocytes from hypoxia induced apoptosis. Exp Cell Res. 350:19–31. 2017. View Article : Google Scholar : PubMed/NCBI
7	Patel K, Gadewar M, Tahilyani V and Patel DK: A review on pharmacological and analytical aspects of diosmetin: A concise report. Chin J Integr Med. 19:792–800. 2013. View Article : Google Scholar : PubMed/NCBI
8	Oak C, Khalifa AO, Isali I, Bhaskaran N, Walker E and Shukla S: Diosmetin suppresses human prostate cancer cell proliferation through the induction of apoptosis and cell cycle arrest. Int J Oncol. 53:835–843. 2018.PubMed/NCBI
9	Chan BC, Ip M, Gong H, Lui SL, See RH, Jolivalt C, Fung KP, Leung PC, Reiner NE and Lau CB: Synergistic effects of diosmetin with erythromycin against ABC transporter over-expressed methicillin-resistant Staphylococcus aureus (MRSA) RN4220/pUL5054 and inhibition of MRSA pyruvate kinase. Phytomedicine. 20:611–614. 2013. View Article : Google Scholar : PubMed/NCBI
10	Yu G, Wan R, Yin G, Xiong J, Hu Y, Xing M, Cang X, Fan Y, Xiao W, Qiu L, et al: Diosmetin ameliorates the severity of cerulein-induced acute pancreatitis in mice by inhibiting the activation of the nuclear factor-κB. Int J Clin Exp Pathol. 7:2133–2142. 2014.PubMed/NCBI
11	Yang Y, Gong XB, Huang LG, Wang ZX, Wan RZ, Zhang P, Zhang QY, Chen Z and Zhang BS: Diosmetin exerts anti-oxidative, anti-inflammatory and anti-apoptotic effects to protect against endotoxin-induced acute hepatic failure in mice. Oncotarget. 8:30723–30733. 2017. View Article : Google Scholar : PubMed/NCBI
12	Liu B, Shi Y, Peng W, Zhang Q, Liu J, Chen N and Zhu R: Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells. Mol Med Rep. 14:159–164. 2016. View Article : Google Scholar : PubMed/NCBI
13	Qiao J, Liu J, Jia K, Li N, Liu B, Zhang Q and Zhu R: Diosmetin triggers cell apoptosis by activation of the p53/Bcl-2 pathway and inactivation of the Notch3/NF-κB pathway in HepG2 cells. Oncol Lett. 12:5122–5128. 2016. View Article : Google Scholar : PubMed/NCBI
14	Zhang Y, Jiang Y and Lu D: Diosmetin suppresses neuronal apoptosis and inflammation by modulating the phosphoinositide 3-kinase (PI3K)_AKT_nuclear factor-κB (NF-κB) signaling pathway. Med Sci Monit. 25:82019.
15	Glick D, Barth S and Macleod KF: Autophagy: Cellular and molecular mechanisms. J Pathol. 221:3–12. 2010. View Article : Google Scholar : PubMed/NCBI
16	Nikoletopoulou V, Markaki M, Palikaras K and Tavernarakis N: Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta. 1833:3448–3459. 2013. View Article : Google Scholar : PubMed/NCBI
17	Fan YJ and Zong WX: The cellular decision between Apoptosis and autophagy. Chin J Cancer. 32:121–129. 2013.PubMed/NCBI
18	Zhang D, Wang W, Sun X, Xu D, Wang C, Zhang Q, Wang H, Luo W, Chen Y, Chen H and Liu Z: AMPK regulates autophagy by phosphorylating BECN1 at threonine 388. Autophagy. 12:1447–1459. 2016. View Article : Google Scholar : PubMed/NCBI
19	Mihaylova MM and Shaw RJ: The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. 13:1016–1023. 2011. View Article : Google Scholar : PubMed/NCBI
20	Yuan M, Zhang L, You F, Zhou J, Ma Y, Yang F and Tao L: MiR-145-5p regulates hypoxia-induced inflammatory response and apoptosis in cardiomyocytes by targeting CD40. Mol Cell Biochem. 431:123–131. 2017. View Article : Google Scholar : PubMed/NCBI
21	Zhang J, He Z, Xiao W, Na Q, Wu T, Su K and Cui X: Overexpression of BAG3 attenuates hypoxia-induced cardiomyocyte apoptosis by inducing autophagy. Cell Physiol Biochem. 39:491–500. 2016. View Article : Google Scholar : PubMed/NCBI
22	Jia Z, Lin L, Huang S, Zhu Z, Huang W and Huang Z: Inhibition of autophagy by berberine enhances the survival of H9C2 myocytes following hypoxia. Mol Med Rep. 16:1677–1684. 2017. View Article : Google Scholar : PubMed/NCBI
23	Zhang S, Zhao Y, Xu M, Yu L, Zhao Y, Chen J, Yuan Y, Zheng Q and Niu X: FoxO3a modulates hypoxia stress induced oxidative stress and apoptosis in cardiac microvascular endothelial cells. PLoS One. 8:e803422013. View Article : Google Scholar : PubMed/NCBI
24	Su Y, Tian H, Wei L, Fu G and Sun T: Integrin β3 inhibits hypoxia-induced apoptosis in cardiomyocytes. Acta Biochim Biophys Sin (Shanghai). 50:658–665. 2018. View Article : Google Scholar : PubMed/NCBI
25	Kanazawa H, Imoto K, Okada M and Yamawaki H: Canstatin inhibits hypoxia-induced apoptosis through activation of integrin/focal adhesion kinase/Akt signaling pathway in H9c2 cardiomyoblasts. PLoS One. 12:e01730512017. View Article : Google Scholar : PubMed/NCBI
26	Liu Q, Ci X, Wen Z and Peng L: Diosmetin alleviates lipopolysaccharide-induced acute lung injury through activating the Nrf2 pathway and inhibiting the NLRP3 inflammasome. Biomol Ther (Seoul). 26:157–166. 2018. View Article : Google Scholar : PubMed/NCBI
27	Zhang Z, Li H, Chen S, Li Y, Cui Z and Ma J: Knockdown of microRNA-122 protects H9c2 cardiomyocytes from hypoxia-induced apoptosis and promotes autophagy. Med Sci Monit. 23:4284–4290. 2017. View Article : Google Scholar : PubMed/NCBI
28	Sung HK, Chan YK, Han M, Jahng JWS, Song E, Danielson E, Berger T, Mak TW and Sweeney G: Lipocalin-2 (NGAL) attenuates autophagy to exacerbate cardiac apoptosis induced by myocardial ischemia. J Cell Physiol. 232:2125–2134. 2017. View Article : Google Scholar : PubMed/NCBI
29	Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, et al: Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 331:456–461. 2011. View Article : Google Scholar : PubMed/NCBI
30	Zhou C, Gu J, Zhang G, Dong D, Yang Q, Chen MB and Xu D: AMPK-autophagy inhibition sensitizes icaritin-induced anticolorectal cancer cell activity. Oncotarget. 8:14736–14747. 2017. View Article : Google Scholar : PubMed/NCBI
31	Zhang H, Liu B, Li T, Zhu Y, Luo G, Jiang Y, Tang F, Jian Z and Xiao Y: AMPK activation serves a critical role in mitochondria quality control via modulating mitophagy in the heart under chronic hypoxia. Int J Mol Med. 41:69–76. 2018.PubMed/NCBI
32	Xu Z, Yan Y, Xiao L, Dai S, Zeng S, Qian L, Wang L, Yang X, Xiao Y and Gong Z: Radiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway. PLoS One. 12:e01759772017. View Article : Google Scholar : PubMed/NCBI
33	Ge A, Liu Y, Zeng X, Kong H, Ma Y, Zhang J, Bai F and Huang M: Effect of diosmetin on airway remodeling in a murine model of chronic asthma. Acta Biochim Biophys Sin (Shanghai). 47:604–611. 2015. View Article : Google Scholar : PubMed/NCBI
34	Yang K, Li WF, Yu JF, Yi C and Huang WF: Diosmetin protects against ischemia/reperfusion-induced acute kidney injury in mice. J Surg Res. 214:69–78. 2017. View Article : Google Scholar : PubMed/NCBI